FFCP PHASE1:Hg19::chr9:12701618..12701630,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=7306 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=12450 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=-14bp_to_ENST00000470909_5end | |||
|coexpression_cluster_id=C58 | |||
|description=CAGE_peak_44_at_TYRP1_5end | |||
|id=chr9:12701618..12701630,+ | |||
|ontology_enrichment_celltype=CL:0000148!2.47e-45!10;CL:0000541!2.47e-45!10;CL:0002195!1.70e-36!2;CL:0002571!1.70e-36!2;CL:0000147!1.78e-32!14;CL:0000710!8.26e-23!20;CL:0002566!2.25e-19!1;CL:0000075!6.05e-17!27;CL:0002077!6.88e-14!33;CL:0000325!9.10e-12!39;CL:0000333!1.11e-10!41;CL:0000133!1.55e-07!59;CL:0002567!2.05e-07!3;CL:0002504!2.79e-07!3;CL:1000279!2.79e-07!3;CL:1000280!2.79e-07!3 | |||
|ontology_enrichment_celltype_v019=CL:0000148;2.38e-27;10!CL:0002567;3.27e-23;3!CL:0000147;6.48e-20;14!CL:0000710;2.58e-14;20!CL:0000138;2.45e-12;6!CL:0000075;6.56e-11;27!CL:0002077;2.79e-09;34!CL:0000153;1.12e-08;9!CL:0000447;1.12e-08;9!CL:0000150;1.12e-08;9!CL:0000151;9.94e-08;36 | |||
|ontology_enrichment_celltype_v019_2=CL:0000148,2.72e-27,10;CL:0000541,2.72e-27,10;CL:0002567,4.09e-23,3;CL:0000147,7.13e-20,14;CL:0000710,2.76e-14,20;CL:0000058,2.19e-12,6;CL:0000138,2.19e-12,6;CL:0000075,6.90e-11,27;CL:0002077,7.08e-09,34;CL:0000153,1.04e-08,9;CL:0000447,1.04e-08,9;CL:0000150,1.12e-08,9;CL:0000151,1.78e-08,36;CL:0000333,3.05e-07,41 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:3371!8.95e-20!1;DOID:4549!8.95e-20!1;DOID:5861!8.95e-20!1;DOID:6496!8.95e-20!1 | |||
|ontology_enrichment_disease_v019=DOID:3371;2.39e-66;1!DOID:4549;2.39e-66;1!DOID:5861;2.39e-66;1!DOID:6496;2.39e-66;1!DOID:201;2.45e-12;6!DOID:0060100;2.45e-12;6 | |||
|ontology_enrichment_disease_v019_2=DOID:3371,1.23e-66,1;DOID:4549,1.23e-66,1;DOID:5861,1.23e-66,1;DOID:6496,1.23e-66,1;DOID:201,2.19e-12,6;DOID:0060100,2.19e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0003127!3.58e-10!2;UBERON:0002418!1.82e-07!3;UBERON:0004755!1.82e-07!3 | |||
|ontology_enrichment_uberon_v019=UBERON:0002418;3.27e-23;3!UBERON:0004755;3.27e-23;3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002418,2.62e-23,3;UBERON:0004755,2.62e-23,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.380987365753014,1.14596527667483,0,0,0.514137463516618,0.901029173531752,1.71495859578347,0,0,0,0,0,0,0,0,0,0,0,0.142977993658148,0,0,0,0.355391948742546,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274537029736055,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.76512253383001,0.225980740780532,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0717222053926763,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p44@TYRP1 | |||
}} |
Revision as of 00:49, 23 January 2014
Short description: | p44@TYRP1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_44_at_TYRP1_5end |
Coexpression cluster: | C58_Melanocyte_melanoma_retina_Retinal_eye_migratory_H9 |
Association with transcript: | -14bp_to_ENST00000470909_5end |
EntrezGene: | TYRP1 |
HGNC: | 12450 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
melanocyte | 2.72e-27 | 10 |
melanoblast | 2.72e-27 | 10 |
light melanocyte | 4.09e-23 | 3 |
pigment cell | 7.13e-20 | 14 |
neurecto-epithelial cell | 2.76e-14 | 20 |
chondroblast | 2.19e-12 | 6 |
chondrocyte | 2.19e-12 | 6 |
columnar/cuboidal epithelial cell | 6.90e-11 | 27 |
ecto-epithelial cell | 7.08e-09 | 34 |
GAG secreting cell | 1.04e-08 | 9 |
carbohydrate secreting cell | 1.04e-08 | 9 |
glandular epithelial cell | 1.12e-08 | 9 |
secretory cell | 1.78e-08 | 36 |
migratory neural crest cell | 3.05e-07 | 41 |
Ontology term | p-value | n |
---|---|---|
cartilage tissue | 2.62e-23 | 3 |
skeletal tissue | 2.62e-23 | 3 |
Ontology term | p-value | n |
---|---|---|
chondrosarcoma | 1.23e-66 | 1 |
extraosseous chondrosarcoma | 1.23e-66 | 1 |
myxoid chondrosarcoma | 1.23e-66 | 1 |
extraskeletal myxoid chondrosarcoma | 1.23e-66 | 1 |
connective tissue cancer | 2.19e-12 | 6 |
musculoskeletal system cancer | 2.19e-12 | 6 |